VitaNova Life Sciences Corp (VNOV) stock: key figures, P/E, revenue and dividend

Industrials · United States

Price
4.48 USD
Market cap
37.32 m USD
P/E (2026)
–
P/S (2026)
12.33
Dividend yield
0.00 %
Net margin
-1.23 %
Return on equity (ROE)
-1.82 %
Return on assets (ROA)
-1.52 %

VitaNova Life Sciences Corp financials

Fiscal year20252026
Revenue2.66 m USD3.03 m USD
Gross profit1.58 m USD910,589.00 USD
Operating income1.21 m USD3,601.00 USD
EBIT1.21 m USD6,581.00 USD
Net income850,746.00 USD-37,304.00 USD
Diluted EPS – continuing operations0.03 USD–

Full history since 2017, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

About VitaNova Life Sciences Corp

VitaNova Life Sciences a consumer health, beauty and lifestyle company, develops, acquires, markets, and sells branded nutritional supplements, functional beverages, and complementary lifestyle products in the United States, Hong Kong, China, and internationally. It operates through two segments, Dietary Supplement and Food Products segment. The company develops and sells nutritional supplements under the GeneCode and AMZ brand names. It is also involved in the sale of healthy food products, including olive juice, white sesame oil, aloe vera drink, etc. In addition, the company provides consulting services, such as general business-advisory and administrative support. The company was formerly known as Yijia Group Corp. and changed its name to VitaNova Life Sciences Corporation in January 2026. VitaNova Life Sciences Corporation was incorporated in 2017 and is based in New York, New York.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 28.10.2026. Details in the risk notice.